Measurement of macrophage-mediated killing of intracellular bacteria, including francisella and mycobacteria

Current Protocols in Immunology

Volumn , Issue SUPPL.93, 2011, Pages

  Elkins, Karen L ^a   Cowley, Siobhán C ^a   Conlan, J Wayne ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cytokine; Francisella; Intracellular bacteria; Intracellular killing; Macrophage; Mycobacteria; T lymphocytes

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERICIDAL ACTIVITY; CELL CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; FRANCISELLA; INTRACELLULAR KILLING; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 82355181239     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baker, C.N., Hollis, D.G., and Thornsberry, C. 1985. Anti-microbial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Micro. 22:212-215.
2. Barel, M., Hovanessian, A.G., Meibom, K., Briand, J.P., Dupuis, M., and Charbit, A. 2008. A novel receptor-ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: Interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol. 8:145.
3. Bosio, C.M., Bielefeldt-Ohmann, H., and Belisle, J.T. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178:4538-4547.
4. Bosio, C.M. and Elkins, K.L. 2001. Susceptibility to secondary Francisella tularensis LVS infection in B cell deficient mice is associated with neutrophilia but not with defects in specific T cell mediated immunity. Infect. Immun. 69:194-203.
5. Carlson, P.E. Jr., Carroll, J.A., O'Dee, D.M., and Nau, G.J. 2007. Modulation of virulence factors in Francisella tularensis determines human macrophage responses. Microb. Pathog. 42:204-214.
6. Chamberlain, R.E. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
7. Cherwonogrodzky, J.W., Knodel, M.H., and Spence, M.R. 1994. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium. Vaccine 12:773-775.
8. Clemens, D.L. and Horwitz, M.A. 2007. Uptake and intracellular fate of Francisella tularensis in human macrophages. Ann. N.Y. Acad. Sci. 1105:160-186.
9. Collazo, C.M., Meierovics, A.I., De Pascalis, R., Wu, T.H., Lyons, C.R., and Elkins, K.L. 2009. T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria. Infect. Immun. 77:2010-2021.
10. Cowley, S.C. and Elkins, K.L. 2003a. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J. Immunol. 171:4689-4699.
11. Cowley, S.C. and Elkins, K.L. 2003b. Multiple T cell subsets control Francisella tularensis LVS intracellular growthwithout stimulation through macrophage interferon gamma receptors. J Exp Med 198:379-389.
12. Cowley, S.C., Myltseva, S.V., and Nano, F.E. 1996. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20:867-874.
13. Cowley, S.C., Hamilton, E., Frelinger, J.A., Su, J., Forman, J., and Elkins, K.L. 2005. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J. Exp. Med. 202:309-319.
14. Cowley, S., Goldberg, M.F., Ho, J.A., Sedgwick, J.D., and Elkins, K.L. 2008. Membrane TNF-α is a suboptimal regulator of nitric oxide production but effectively controls apoptosis during Francisella tularensis LVS infection. J. Infect. Dis. 198:284-292.
15. Dennis, D.T., Inglesby, T.V., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Layton, M., Lillibridge, S.R., McDade, J.E., Osterholm, M.T., O'Toole, T., Parker, G., Perl, T.M., Russell, P.K., and Tonat, K. 2001. Tularemia as a biological weapon: Medical and public health management. JAMA 285:2763-2773.
16. Eigelsbach, H.T. and Downs, C.M. 1961. Prophylactic effectiveness of live and killed tularemia vaccines. J. Immunol. 87:415-425.
17. Eigelsbach, H.T., Hunter, D.H., Janssen, W.A., Dangerfield, H.G., and Rabinowitz, S.G. 1975. Murine model for study of cell-mediated immunity: Protection against death from fully virulent Francisella tularensis infection. Infect. Immun. 12:999-1005.
18. Elkins,K.L., Cooper, A.,Colombini, S.M., Cowley, S.C., and Kieffer, T.L. 2002. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subof Interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70:1936-1948.
19. Elkins, K.L., Cowley, S.C., and Bosio, C.M. 2003. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5:132-142.
20. Hazlett, K.R., Caldon, S.D., McArthur, D.G., Cirillo, K.A., Kirimanjeswara, G.S., Magguilli, M.L., Malik, M., Shah, A., Broderick, S., Golovliov, I., Metzger, D.W., Rajan, K., Sellati, T.J., and Loegering, D.J. 2008. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect. Immun. 76:4479-4488.
21. Kolibab, K., Parra, M., Yang, A.L., Perera, L.P., Derrick, S.C., and Morris, S.L. 2009. A practical in vitro growth inhibition assay for the evaluation of TB vaccines. Vaccine 28:317-322.
22. Mackaness, G.B. 1962. Cellular resistance to infection. J. Exp. Med. 116:381-406.
23. Mackaness, G.B. 1964. The immunological basis of acquired cellular resistance. J. Exp. Med. 120:105-120.
24. Mackaness, G.B. 1969. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129:973-992.
25. Pasetti, M.F., Cuberos, L., Horn, T.L., Shearer, J.D., Matthews, S.J., House, R.V., and Sztein, M.B. 2008. An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes. Vaccine 26:1773-1785.
26. Pierini, L.M. 2006. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell Microbiol. 8:1361-1370.
27. Sandström, G. 1994. The tularaemia vaccine. J. Chem. Technol. Biotechnol. 59:315-320.
28. Schulert, G.S. and Allen, L.A. 2006. Differential infection of mononuclear phagocytes by Francisella tularensis: Role of the macrophage mannose receptor. J. Leukoc. Biol. 80:563-571.
29. Sjöstedt, A. 2007. Tularemia: History, epidemiology, pathogen physiology, and clinical manifestations. Ann. N.Y. Acad. Sci. 1105:1-29.
30. Tärnvik, A., Eriksson, M., Sändstrom, G., and Sjöstedt, A. 1992. Francisella tularensis: A model for studies of the immune response to intracellular bacteria in man. Immunology 76:349-354.